🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will assess the efficacy and safety of mosunetuzumab in combinat...
Status
Active Not Recruiting
Location
City of Hope Cancer Center
Start Date
2022-04-25
Trial ID
NCT05171647
Treatments Being Tested
Multicentric phase II trial to evaluate efficacy and safety of ibrutinib in...
Status
Completed
Location
Hospital Universitario Son Espases
Start Date
2016-04-07
Trial ID
NCT02692248
Treatments Being Tested
This is a prospective, single-arm, multicenter, phase II clinical trial to ...
Status
Not Yet Recruiting
Location
Daping Hospital, Third Military Medical University (Army Medical University)
Start Date
2025-02-01
Trial ID
NCT06778902
Treatments Being Tested
The purpose of this study is to determine the recommended dose of CMC544 ad...
Status
Completed
Location
AZ Sint Jan
Start Date
2012-12
Trial ID
NCT01562990
Treatments Being Tested
This is a multicenter, randomized, controlled, open-label Phase III clinica...
Status
Recruiting
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2025-01-06
Trial ID
NCT06792253
This is a randomized, open label, multicenter phase III trial comparing the...
Status
Completed
Location
Moores UC San Diego Cancer Center
Start Date
2019-05-09
Trial ID
NCT03570892
The purpose of this study is to investigate efficacy and safety of Lenalido...
Status
Unknown
Location
The first Affiliated Hospital Of Nanjing Medical University(JiangSu Province Hospital)
Start Date
2020-06-14
Trial ID
NCT04432402
Treatments Being Tested
This is an open-label, multicenter, randomized, phase 3 trial to evaluate t...
Status
Unknown
Location
Affiliated Cancer Hospital and Institute of Guangzhou Medical University
Start Date
2022-02-15
Trial ID
NCT05244642
Treatments Being Tested
This is a Phase III randomized, double-blind, positive controlled study to ...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2026-03-20
Trial ID
NCT07409428
Treatments Being Tested
This study evaluates the addition of nivolumab to gemcitabine, oxaliplatin ...
Status
Completed
Location
Landeskrankenhaus Feldkirch
Start Date
2017-12-05
Trial ID
NCT03366272
Treatments Being Tested